MRI changes breast cancer treatment choice; increases time to treatment

April 11, 2008

More than a quarter of breast cancer patients who had an MRI examination before their initial surgical treatment had their treatment change, according to a study out of Yale University School of Medicine.

The study included 110 who had an MRI examination before treatment and 374 who did not undergo an MRI examination. "MRI prompted biopsy of 70 sites in 44 patients, said Carol Lee, MD, an author of the study, now at Memorial Sloan Kettering Cancer Center in NY. Sixteen additional sites of cancer were found in 13 (12%) women, she said.

Surgical treatment was changed in 31 (28%) cases, she added. Fifteen patients had mastectomy rather than lumpectomy. Six had more extensive lumpectomy and three had treatment for cancer that was detected in the opposite breast. "Seven others made a decision to have bilateral mastectomy after a suspicious finding was seen on MRI but before additional cancer was confirmed by a biopsy; it turned out that none had cancer in the contralateral breast" Dr. Lee noted. "While we can't show definitively that these women made the choice to have a mastectomy due to concerns generated by findings on the MR images, this remains a possibility, and patients and their doctors need to take this into consideration before deciding to have an MRI examination before treatment," Dr. Lee said.

Adding an MRI examination also delayed treatment. "The mean interval between diagnosis and definitive surgery in the group that had the MRI examination was 41 days compared to 27 days for the patients who did not undergo an MRI examination," she said.

"Breast MRI is a very useful tool for assessing extent of tumor in the breast, however, there are downsides that need to be taken into consideration," Dr. Lee emphasized.
-end-
The full results of this study will be presented on Tuesday, April 15, 2008 during the American Roentgen Ray Society's annual meeting in Washington, DC.

American College of Radiology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.